GlassScriptPhysician profile
Whitney Leonard
NPI 1457888729
$2,820.39
in general payments reported to CMS, 2019-2025
24 companies · $638 in 2025
The $638 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $629 · 2023: $827 · 2024: $619 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,084.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $483.62 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $299.00 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $262.81 | 2022-2025 | |
| Astellas Pharma US INC | $253.03 | 2022-2024 | Veozah |
| Organon LLC | $203.20 | 2022-2025 | Nexplanon |
| Myovant Sciences INC. | $162.80 | 2021-2022 | |
| Pfizer INC. | $151.53 | 2021-2025 | |
| Hologic Sales and Service, LLC | $144.45 | 2024-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Therapeuticsmd, INC. | $125.17 | 2022 | |
| Exeltis, USA INC. | $109.13 | 2022-2025 | Slynd |
| Vertex Pharmaceuticals Incorporated | $103.23 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $92.95 | 2022-2025 | |
| Sage Therapeutics, LLC | $91.46 | 2022-2024 | |
| Agile Therapeutics, INC. | $61.24 | 2022-2023 | Twirla |
| Minerva Surgical, INC | $56.55 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $49.24 | 2021-2022 | |
| Coopersurgical, INC. | $40.21 | 2024-2025 | Paragard T 380a, Endosee |
| Millicent US INC | $33.01 | 2024-2025 | Femring, Intrarosa |
| Urovant Sciences INC | $21.82 | 2022 | |
| Conmed Corporation | $19.15 | 2025 | Airseal |
| Axonics, INC. | $16.26 | 2024 | Bulkamid |
| Meditrina | $15.83 | 2023 | |
| Davol INC. | $13.03 | 2023 | Arista Ah Flexitip |
| Medtronic, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.